Similar articles

• Genta initiates trials with Genasense.

  [No authors listed] [No authors listed] Expert Rev Anticancer Ther. 2002 Feb;2(1):6. Expert Rev Anticancer Ther. 2002. PMID: 12113068 No abstract available.
• Clinical trials referral resource. Current clinical trials of bortezomib.

  Wright JJ, Zerivitz K, Schoenfeldt M. Wright JJ, et al. Oncology (Williston Park). 2003 May;17(5):677-80, 683-6, 691-2. Oncology (Williston Park). 2003. PMID: 12800794 No abstract available.
• Individualized therapy of disseminated cancer using malignant melanoma as a model.

  Hauschild A, Egberts F, Russo P, Kähler KC. Hauschild A, et al. Cancer Metastasis Rev. 2006 Jun;25(2):253-6. doi: 10.1007/s10555-006-8505-5. Cancer Metastasis Rev. 2006. PMID: 16770537 Review.
• Antisense strategies for oncogene inactivation.

  Stein CA, Benimetskaya L, Mani S. Stein CA, et al. Semin Oncol. 2005 Dec;32(6):563-72. doi: 10.1053/j.seminoncol.2005.09.003. Semin Oncol. 2005. PMID: 16338422 Review.
• Recurrent small cell lung cancer: update.

  Glisson BS. Glisson BS. Semin Oncol. 2003 Feb;30(1):72-8. doi: 10.1053/sonc.2003.50014. Semin Oncol. 2003. PMID: 12635091 Review.